Connection

Mark Jit to Vaccines

Back to Details
This is a "connection" page, showing publications Mark Jit has written about Vaccines.
Mark Jit
Connection Strength
0.231
Vaccines
  1. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Glob Health. 2020 10; 8(10):e1264-e1272.
    View in: PubMed
    Score: 0.055
  2. A global agenda for older adult immunization in the COVID-19 era: A roadmap for action. Vaccine. 2021 08 31; 39(37):5240-5250.
    View in: PubMed
    Score: 0.054
  3. A Scoping Review of Investment Cases for Vaccines and Immunization Programs. Value Health. 2019 08; 22(8):942-952.
    View in: PubMed
    Score: 0.050
  4. The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries. Health Aff (Millwood). 2018 02; 37(2):316-324.
    View in: PubMed
    Score: 0.046
  5. COVID-19 vaccine challenges: What have we learned so far and what remains to be done? Health Policy. 2021 05; 125(5):553-567.
    View in: PubMed
    Score: 0.014
  6. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017. Vaccine. 2018 02 08; 36(7):921-931.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.